Replies to post #1278 on Revance Therapeutics Inc (RVNC)

[dewophile]

For reference the phase 2 trial completed enrollment in november of 2016 and reported top line may of 2017. the phase 3 is looking out to 36 weeks vs 24 weeks, but even so this implies a readout in august of 2020
Short of the outcome of the BLA filing this is probably the most significant event for RVNC in 2020